215 related articles for article (PubMed ID: 9685902)
21. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
22. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
23. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
24. Effects of various absorption enhancers on transport of clodronate through Caco-2 cells.
Raiman J; Törmälehto S; Yritys K; Junginger HE; Mönkkönen J
Int J Pharm; 2003 Aug; 261(1-2):129-36. PubMed ID: 12878401
[TBL] [Abstract][Full Text] [Related]
25. Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.
Hamman JH; Stander M; Kotzé AF
Int J Pharm; 2002 Jan; 232(1-2):235-42. PubMed ID: 11790507
[TBL] [Abstract][Full Text] [Related]
26. Intestinal drug absorption enhancers: synergistic effects of combinations.
Enslin GM; Hamman JH; Kotze AF
Drug Dev Ind Pharm; 2008 Dec; 34(12):1343-9. PubMed ID: 18686089
[TBL] [Abstract][Full Text] [Related]
27. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
29. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
31. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
32. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells.
Mao S; Germershaus O; Fischer D; Linn T; Schnepf R; Kissel T
Pharm Res; 2005 Dec; 22(12):2058-68. PubMed ID: 16170693
[TBL] [Abstract][Full Text] [Related]
33. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.
Duizer E; Gilde AJ; Versantvoort CH; Groten JP
Toxicol Appl Pharmacol; 1999 Mar; 155(2):117-26. PubMed ID: 10053166
[TBL] [Abstract][Full Text] [Related]
34. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
35. Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers.
Dorkoosh FA; Setyaningsih D; Borchard G; Rafiee-Tehrani M; Verhoef JC; Junginger HE
Int J Pharm; 2002 Jul; 241(1):35-45. PubMed ID: 12086719
[TBL] [Abstract][Full Text] [Related]
36. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers.
Shah PJ; Jogani VV; Mishra P; Mishra AK; Bagchi T; Misra AR
Nucl Med Commun; 2007 Aug; 28(8):653-9. PubMed ID: 17625388
[TBL] [Abstract][Full Text] [Related]
37. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
38. N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
Benediktsdóttir BE; Gudjónsson T; Baldursson Ó; Másson M
Eur J Pharm Biopharm; 2014 Jan; 86(1):55-63. PubMed ID: 23608635
[TBL] [Abstract][Full Text] [Related]
39. Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers.
Sakai M; Noach AB; Blom-Roosemalen MC; de Boer AG; Breimer DD
Biochem Pharmacol; 1994 Sep; 48(6):1199-210. PubMed ID: 7524505
[TBL] [Abstract][Full Text] [Related]
40. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement.
Schipper NG; Olsson S; Hoogstraate JA; deBoer AG; Vårum KM; Artursson P
Pharm Res; 1997 Jul; 14(7):923-9. PubMed ID: 9244151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
